Medical Gas and Equipment Market

The medical gas and equipment market is projected to reach USD 24.62 billion by 2031 from USD 18.50 billion in 2026, at a CAGR of 5.9% during the forecast period.

The expansion of the medical gas and equipment market mainly stems from healthcare systems worldwide struggling to meet the growing demand for respiratory and critical care services. This rise is driven by the increasing number of patients with chronic conditions such as COPD, asthma, cardiovascular diseases, as well as coronavirus and cancer. These patients require long-term, effective therapy using medicinal gases and devices that safely supply oxygen and nitrous oxide. Supporting this trend is the aging population, which typically needs more frequent and extended medical treatments. Furthermore, growth and modernization of healthcare facilities, especially in developing countries, along with government investments in hospitals, surgical centers, and home care, contribute to the ongoing installation and upgrade of medical gas systems. Advances in smart gas delivery, automation, and portable technology not only improve treatment effectiveness but also increase accessibility in home healthcare. Overall, these factors are sustaining a consistent rise in demand for medical gases and their associated devices.

To know about the assumptions considered for the study download the pdf brochure

Leading players in the medical gas and equipment sector include Air Liquide, Linde plc, Air Products and Chemicals Inc., Messer SE & Co. KGaA, and Taiyo Nippon Sanso Corporation. These multinational giants maintain strong global standings through extensive production capabilities, innovative product offerings, and established distribution channels. They supply a diverse range of medical gases such as oxygen, nitrogen, nitrous oxide, and specialty gas mixtures, along with the necessary delivery systems and services tailored for hospitals, clinics, and home care. Their consistent reinvestment in advanced gas production technologies, digital monitoring, and safety-compliant infrastructure ensures a reliable supply in both acute and long-term care environments—key to their leadership. Moreover, their strategic presence across North America, Europe, and the Asia Pacific, coupled with partnerships, acquisitions, and long-term healthcare contracts, provides them with competitive advantages that secure a significant share of the global medical gas and equipment market.

• In April 2025, Air Liquide introduced ECO ORIGIN as an environmentally friendly medical and industrial gas solution complementary to client needs. It covers essential gases such as oxygen, nitrogen, argon, and carbon dioxide, produced from pure, renewable energy sources and accompanied by an ISO-standardized carbon footprint from production to delivery.
• In June 2025, ESAB‍‌‍‍‌‍‌‍‍‌ Corporation (GCE) has improved its medical gas equipment portfolio by purchasing Delta P Gas Equipment, a company located in Italy, and by making a decision to buy Aktiv Technologies in India. The acquisitions allow ESAB to provide more complete medical central gas systems solutions, have a stronger global presence, and be more safety- and regulatory-compliance-oriented in their gas control equipment offering.

Air Liquide (France)

Air Liquide S.A., a renowned French multinational, has operated globally for over a century. Headquartered in Paris, it leads in the production and distribution of industrial and medical gases, along with related technologies and services. Founded in 1902, Air Liquide now operates in over 70 countries, serving hundreds of thousands of clients, including healthcare providers and patients worldwide. Its Medical Gases and Equipment Division offers a wide range of medical gases and devices, crucial for hospitals and home healthcare, such as medical oxygen for respiratory and intensive care, nitrous oxide and oxygen mixtures for analgesia, and nitric oxide for critical care, all delivered with strict safety and quality standards through hospital systems and installations. The company's specialized branch, Air Liquide Healthcare, provides home healthcare services and innovative gas delivery solutions, supporting chronic disease treatment outside hospitals and reaching millions globally. Its extensive production and distribution facilities, strong R&D commitment, and long-term contracts with medical institutions firmly establish Air Liquide as a leader in the medical gases and equipment market.

Linde PLC (Germany)

Linde PLC is a leading global industrial gas and engineering firm, significantly involved in the US medical gas and equipment sector. Created through the 2018 merger of Germany's Linde AG and the US-based Praxair, it excels in supplying medical gases like oxygen for respiratory therapy, nitrogen for preservation, and helium for medical imaging, along with delivery infrastructure and services for hospitals, clinics, laboratories, and nursing facilities across the US. Linde's healthcare portfolio combines high-quality gas production with comprehensive distribution and support, backed by one of the largest gas supply networks in the country. Its US operations reliably provide medical gases and equipment, helping healthcare providers maintain continuous care while adhering to strict safety and quality standards. In addition to essential hospital supplies, Linde also offers home care respiratory therapy through subsidiaries and partners, strengthening its presence in the healthcare industry across various care settings.

MARKET RANKING

Air Liquide, Linde plc, Air Products and Chemicals Inc., Messer SE & Co. KGaA, and Taiyo Nippon Sanso Corporation are the leading companies in the global medical gas and equipment industry. Their prominence stems from their large size, advanced technology, and worldwide presence. These companies hold significant market share due to their extensive medical gas manufacturing capabilities, reliable distribution networks, and established contracts with hospitals, healthcare providers, and home care services. With their broad range of healthcare products, substantial investments in medical gas infrastructure, and strong presence in Europe, North America, and the Asia Pacific, Air Liquide and Linde plc are ranked at the top. Air Products and Chemicals remains competitive primarily because of its cutting-edge technologies, dependable supply of bulk and packaged gases, and a robust presence in the U.S. market. Messer SE & Co. KGaA and Taiyo Nippon Sanso Corporation challenge the competition through their strong leadership in Europe and Asia, respectively, supported by ongoing growth, strategic alliances, and a focus on high-quality medical gas solutions.

Related Reports:

Medical Gas and Equipment Market by Medical Gas [(Oxygen, Nitrogen, Carbon Dioxide, Medical Air), Gas Mixtures], Equipment (Manifolds, Valves, Flowmeters), Application (Therapeutic, Diagnostic, Pharmaceutical), and End Users - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]